TELMISIGN AM Tablet by Dr Precision is a high-quality fixed-dose combination medication specifically formulated for the effective management of essential hypertension. Combining Telmisartan, an angiotensin II receptor blocker (ARB), with Amlodipine, a calcium channel blocker (CCB), this dual-action tablet targets elevated blood pressure through complementary mechanisms. Telmisartan acts by blocking angiotensin II receptors to prevent vasoconstriction, promoting vasodilation and reducing systemic vascular resistance. Meanwhile, Amlodipine inhibits calcium ion influx into vascular and cardiac muscle cells, further improving vessel relaxation and blood flow. This high-potency combination provides enhanced 24-hour blood pressure control, supporting cardiovascular protection and lowering the risk of hypertension-related complications such as left ventricular hypertrophy and chronic kidney disease. Manufactured under stringent GMP standards by Bluepill Express, TELMISIGN AM undergoes rigorous quality assurance including assays, dissolution, microbial safety, and stability testing to ensure efficacy and safety. The once-daily dose enhances patient adherence, making it highly suitable for patients requiring dual antihypertensive therapy. It is especially preferred where monotherapy fails to achieve target blood pressure levels. Proper usage under medical advice is crucial, with awareness of contraindications such as pregnancy and caution advised in cases of severe hepatic or renal impairment. Overall, TELMISIGN AM delivers a reliable, clinically proven solution for comprehensive hypertension management in a single convenient tablet.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Telmisartan (ARB) and Amlodipine (CCB) |
| Formulation Type | Fixed-dose combination tablet |
| Therapeutic Use | Management of essential hypertension |
| Mechanism of Action | Dual action via angiotensin II receptor blockade and calcium channel blockade |
| Dosage Frequency | Once daily |
| Manufacturer | Dr Precision (Bluepill Express) |
| Quality Standards | GMP compliant with rigorous quality testing |
| Patient Benefits | Improved blood vessel relaxation, enhanced blood flow, and cardiovascular risk reduction |
| Packaging | Standardized packaging ensuring shelf stability and product integrity |
| Common Side Effects | Dizziness, ankle swelling, fatigue (generally well tolerated) |
| Attributes | Description |
|---|---|
| Active Ingredient 1 | Telmisartan |
| Active Ingredient 2 | Amlodipine |
| Drug Class 1 | Angiotensin II receptor blocker (ARB) |
| Drug Class 2 | Calcium channel blocker (CCB) |
| Indications | Essential hypertension requiring dual therapy |
| Contraindications | Pregnancy, severe hepatic or renal impairment |
| Dosage Form | Oral tablet |
| Packaging Type | Blister packing or bottle (varies) |
| Stability Testing | Assay, dissolution, microbial, and stability tests performed |
| Manufacturing Compliance | GMP certified facility |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
TELMISIGN AM combines Telmisartan, which blocks angiotensin II receptors to induce vasodilation, with Amlodipine, which inhibits calcium influx in vascular muscles, resulting in enhanced blood vessel relaxation and superior blood pressure control than monotherapy.
Manufactured under GMP compliance by Bluepill Express, TELMISIGN AM undergoes assays to verify active ingredient potency, dissolution tests for bioavailability, microbial testing for safety, and stability analysis to ensure product shelf life and effectiveness.
TELMISIGN AM is particularly beneficial for patients with essential hypertension who do not achieve optimal control with single-agent therapy, and those at risk of cardiovascular complications, left ventricular hypertrophy, or chronic kidney disease.
TELMISIGN AM is contraindicated during pregnancy and must be used cautiously in patients with severe hepatic or renal impairment due to altered drug metabolism or excretion risks.
The once-daily dosing regimen simplifies the hypertension treatment plan, making it easier for patients to adhere consistently to medication schedules, thereby enhancing blood pressure control and minimizing cardiovascular risks.
Country Of Origin: India
TELMISIGN AM Tablet is a combination of Telmisartan and Amlodipine, used for the effective treatment of high blood pressure. This dual-action formulation helps in relaxing blood vessels and improving blood flow, providing enhanced control over hypertension and reducing cardiovascular risks.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
TELMISIGN AM Tablet is a fixed-dose combination medication that combines two potent antihypertensive agents: Telmisartan, an angiotensin II receptor blocker (ARB), and Amlodipine, a calcium channel blocker (CCB). This synergistic formulation is designed for patients requiring dual therapy to achieve optimal blood pressure control when monotherapy is insufficient.
Telmisartan works by blocking the angiotensin II receptor, thereby preventing vasoconstriction and promoting vasodilation, which reduces systemic vascular resistance and lowers blood pressure. Amlodipine complements this action by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, further aiding in vessel relaxation and improved circulation.
TELMISIGN AM is indicated for the management of essential hypertension, especially in patients who benefit from both ARB and CCB action. The once-daily dosing enhances patient adherence, while the dual mechanism of action ensures comprehensive blood pressure control throughout the day and night.
Manufactured under strict GMP compliance by Bluepill Express, TELMISIGN AM undergoes rigorous quality checks, including assay, dissolution, microbial testing, and stability analysis. It is available in standard packaging formats that ensure shelf-life stability and product integrity.
This combination is particularly beneficial for hypertensive patients at risk of cardiovascular events, left ventricular hypertrophy, or chronic kidney disease. TELMISIGN AM is generally well tolerated, though some patients may experience side effects such as dizziness, ankle swelling, or fatigue. It is contraindicated in pregnancy and should be used with caution in patients with severe hepatic or renal impairment.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
